Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Nikole J Byrne"'
Autor:
Nikole J. Byrne, BSc, Nirmal Parajuli, PhD, Jody L. Levasseur, BSc, Jamie Boisvenue, BTech, Donna L. Beker, Grant Masson, BSc, Paul W.M. Fedak, MD, PhD, Subodh Verma, MD, PhD, Jason R.B. Dyck, PhD
Publikováno v:
JACC: Basic to Translational Science, Vol 2, Iss 4, Pp 347-354 (2017)
This study sought to determine whether the sodium/glucose cotransporter 2 (SGLT2) inhibitor empagliflozin improved heart failure (HF) outcomes in nondiabetic mice. The EMPA-REG OUTCOME (Empagliflozin, Cardiovascular Outcome Event Trial in Type 2 Diab
Externí odkaz:
https://doaj.org/article/b8f761721afe4ce8a10d25385c71df66
Publikováno v:
Circ Res
As a muscular pump that contracts incessantly throughout life, the heart must constantly generate cellular energy to support contractile function and fuel ionic pumps to maintain electrical homeostasis. Thus, mitochondrial metabolism of multiple meta
Autor:
Maria Areli Lorenzana-Carrillo, Keshav Gopal, Nikole J. Byrne, Saymon Tejay, Bruno Saleme, Subhash K. Das, Yongneng Zhang, Alois Haromy, Farah Eaton, Michelle Mendiola Pla, Dawn E. Bowles, Jason R. B. Dyck, John R. Ussher, Evangelos D. Michelakis, Gopinath Sutendra
Publikováno v:
Science translational medicine. 14(669)
Pyruvate kinase M2 (PKM2) is a glycolytic enzyme that translocates to the nucleus to regulate transcription factors in different tissues or pathologic states. Although studied extensively in cancer, its biological role in the heart remains unresolved
Autor:
Jason R.B. Dyck, John M. Seubert, Wentong Long, Peter E. Light, Taylor Palechuk, Chloe Schneider, Amy J. Barr, Nikole J. Byrne, Jyoti Singh, Khaled Barakat, Ahmed M. Darwesh, Koenraad Philippaert, Subha Kalyaanamoorthy, Mohammad Fatehi, Jordan Wong, Shubham Soni, Zaid H. Maayah
Publikováno v:
Circulation
Supplemental Digital Content is available in the text.
Background: SGLT2 (sodium/glucose cotransporter 2) inhibitors exert robust cardioprotective effects against heart failure in patients with diabetes, and there is intense interest to identify
Background: SGLT2 (sodium/glucose cotransporter 2) inhibitors exert robust cardioprotective effects against heart failure in patients with diabetes, and there is intense interest to identify
Publikováno v:
Free Radic Biol Med
Even in the absence of coronary artery disease and hypertension, diabetes mellitus (DM) may increase the risk for heart failure development. This risk evolves from functional and structural alterations induced by diabetes in the heart, a cardiac enti
Autor:
Aleksandre Tarkhnishvili, Christoph Koentges, Katharina Pfeil, Johannes Gollmer, Nikole J Byrne, Ivan Vosko, Julia Lueg, Laura Vogelbacher, Stephan Birkle, Sibai Tang, Timothy Bon-Nawul Mwinyella, Michael M Hoffmann, Katja E Odening, Nathaly Anto Michel, Dennis Wolf, Peter Stachon, Ingo Hilgendorf, Markus Wallner, Senka Ljubojevic-Holzer, Dirk von Lewinski, Peter Rainer, Simon Sedej, Harald Sourij, Christoph Bode, Andreas Zirlik, Heiko Bugger
Publikováno v:
Tarkhnishvili, Aleksandre; Koentges, Christoph; Pfeil, Katharina; Gollmer, Johannes; Byrne, Nikole J; Vosko, Ivan; Lueg, Julia; Vogelbacher, Laura; Birkle, Stephan; Tang, Sibai; Bon-Nawul Mwinyella, Timothy; Hoffmann, Michael M; Odening, Katja E; Michel, Nathaly Anto; Wolf, Dennis; Stachon, Peter; Hilgendorf, Ingo; Wallner, Markus; Ljubojevic-Holzer, Senka; von Lewinski, Dirk; ... (2022). Effects of Short Term Adiponectin Receptor Agonism on Cardiac Function and Energetics in Diabetic db/db Mice. Journal of lipid and atherosclerosis, 11(2), pp. 161-177. Korean Society of Lipid and Atherosclerosis 10.12997/jla.2022.11.2.161
Objective Impaired cardiac efficiency is a hallmark of diabetic cardiomyopathy in models of type 2 diabetes. Adiponectin receptor 1 (AdipoR1) deficiency impairs cardiac efficiency in non-diabetic mice, suggesting that hypoadiponectinemia in type 2 di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59b2134cd9ecca0e90f480f595509bb2
Autor:
Nikole J. Byrne, Constantin N. Witt, Christoph Koentges, Katharina Pfeil, Thomas Pusdrowski, Johannes Gollmer, Ivan Vosko, Christoph Bode, Andreas Zirlik, Heiko Bugger
Publikováno v:
Journal of Molecular and Cellular Cardiology. 173:67
Autor:
Aleksandre, Tarkhnishvili, Christoph, Koentges, Katharina, Pfeil, Johannes, Gollmer, Nikole J, Byrne, Ivan, Vosko, Julia, Lueg, Laura, Vogelbacher, Stephan, Birkle, Sibai, Tang, Timothy, Bon-Nawul Mwinyella, Michael M, Hoffmann, Katja E, Odening, Nathaly Anto, Michel, Dennis, Wolf, Peter, Stachon, Ingo, Hilgendorf, Markus, Wallner, Senka, Ljubojevic-Holzer, Dirk, von Lewinski, Peter, Rainer, Simon, Sedej, Harald, Sourij, Christoph, Bode, Andreas, Zirlik, Heiko, Bugger
Publikováno v:
Journal of lipid and atherosclerosis. 11(2)
Impaired cardiac efficiency is a hallmark of diabetic cardiomyopathy in models of type 2 diabetes. Adiponectin receptor 1 (AdipoR1) deficiency impairs cardiac efficiency in non-diabetic mice, suggesting that hypoadiponectinemia in type 2 diabetes may
Autor:
Dyonne Y. Vos, Jody Levasseur, Jonathan D. Schertzer, John M. Seubert, Mourad Ferdaoussi, John R. Ussher, Zaid H. Maayah, Mya A. Schmidt, Abrar S. Alam, Nikole J. Byrne, Jason R.B. Dyck, Shingo Takahara, Ahmed M. Darwesh, Rami Al Batran, Donna L. Beker, Shubham Soni
Publikováno v:
Circulation. Heart failure. 13(6)
Background: Previous studies have shown beneficial effects of acute infusion of the primary ketone body, β-hydroxybutyrate, in heart failure (HF). However, whether chronic elevations in circulating ketones are beneficial remains unknown. Methods: To
Autor:
Martin E. Young, Ahmed M. Darwesh, Zaid H. Maayah, Gary Sweeney, Nikole J. Byrne, Subodh Verma, Jason R.B. Dyck, Nirmal Parajuli, Shingo Takahara, Mourad Ferdaoussi, John M. Seubert, Ayman O.S. El-Kadi, Branko Braam, Nobutoshi Matsumura, Dyonne Y. Vos, Peter E. Light, Jody Levasseur, James Won Suk Jahng
Publikováno v:
Circulation: Heart Failure. 13
Background: Although empagliflozin was shown to profoundly reduce cardiovascular events in diabetic patients and blunt the decline in cardiac function in nondiabetic mice with established heart failure (HF), the mechanism of action remains unknown. M